title: Radiopharmaceuticals in paraganglioma imaging: too many members on board?
authors.affiliation: Department of Nuclear Medicine, La Timone University Hospital, European Center for Research in Medical Imaging, Aix-Marseille University, 264 rue Saint-Pierre, 13385, Marseille, France. david.taieb@ap-hm.fr.
authors.forename: David
authors.initials: D
authors.lastname: Taïeb
authors.affiliation: Cancer Imaging and Neuroendocrine Tumour Service, Peter MacCallum Cancer Centre, Melbourne, Australia.|The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
authors.forename: Rodney J
authors.initials: RJ
authors.lastname: Hicks
authors.affiliation: Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health, Bethesda, MD, 20892, USA.
authors.forename: Karel
authors.initials: K
authors.lastname: Pacak
mesh_terms: D019797:3-Iodobenzylguanidine / Q000737:chemistry; D000465:Algorithms; D003952:Diagnostic Imaging / Q000379:methods / Q000639:trends; D019788:Fluorodeoxyglucose F18 / Q000737:chemistry; D006801:Humans; D009154:Mutation; D010235:Paraganglioma / Q000000981:diagnostic imaging*; D010641:Phenotype; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000737:chemistry*; D013385:Succinate Dehydrogenase / Q000235:genetics
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D019797:3-Iodobenzylguanidine; D013385:Succinate Dehydrogenase